Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study
Sheldon Morris(University of California, San Diego), Jeffrey D. Klausner(University of Southern California), Mark Sarno, Purnima Madhivanan(University of Arizona), Michael R. Wierzbicki(Emmes (United States)), Toni Waymer(Social and Scientific Systems (United States)), Constance Brown(Los Angeles Clinical Trials), Claire Bristow(AbbVie (United States)), Leandro Mena(Emory University), Lydie Hazan(AXIS Clinical Trials), Saara Schwartz(Florida International University), Audrey L. French(John H. Stroger, Jr. Hospital of Cook County), Susan Philip(Fairleigh Dickinson University), Lenore Asbel(Philadelphia Department of Public Health), Charlotte A. Gaydos(Johns Hopkins University), David Styers(Micro Focus (United States))
Cited by 105
Related Papers
Assessing differential impacts of COVID-19 on black communities
|Annals of Epidemiology|2020|1.2k
Soluble Urokinase Receptor and Chronic Kidney Disease
|New England Journal of Medicine|2015|415
So you think you can PLS-DA?
|BMC Bioinformatics|2020|401
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
|Annals of Clinical Microbiology and Antimicrobials|2006|384